The Use of Rifampicin‐Miconazole–Impregnated Catheters Reduces the Incidence of Femoral and Jugular Catheter‐Related Bacteremia | Zendy

Leonardo Lorente | Zendy; María Lecuona | Zendy; María José Ramos | Zendy; Alejandro Jiménez | Zendy; María L. Mora | Zendy; A. Sierra | Zendy

Open Access

The Use of Rifampicin‐Miconazole–Impregnated Catheters Reduces the Incidence of Femoral and Jugular Catheter‐Related Bacteremia

Author(s) -

Leonardo Lorente,

María Lecuona,

María José Ramos,

Alejandro Jiménez,

María L. Mora,

A. Sierra

Publication year - 2008

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/592253

Subject(s) - medicine , bacteremia , miconazole , catheter , incidence (geometry) , surgery , rifampicin , anesthesia , antibiotics , dermatology , pathology , microbiology and biotechnology , antifungal , tuberculosis , physics , optics , biology

The guidelines of the Centers for Disease Control and Prevention do not recommend the use of an antimicrobial- or antiseptic-impregnated catheter for short-term use. In previous studies, we have found a higher incidence of central venous catheter-related bacteremia among patients with femoral and central jugular accesses than among patients with other venous accesses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research